The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 5/Signature 1
From BugSigDB
Reviewed Marked as Reviewed by Folakunmi on 2024-4-9
Source: Supp. Table S10
Description: Differential abundance between responders and non-responders to Anti–PD-1/PD-L1 immunotherapy in patients with Gastrointestinal Cancer (Responders, n=25; Non-responders, n=15)
Abundance in Group 1: increased abundance in Non-responders to anti–PD-1/PD-L1 immunotherapy
| NCBI | Quality Control | Links |
|---|---|---|
| Latilactobacillus curvatus | ||
| Catenibacterium mitsuokai | ||
| Dialister succinatiphilus | ||
| unclassified Yersinia (in: enterobacteria) |
Revision editor(s): Scholastica
